Tri Locum Partners LP Intra Cellular Therapies, Inc. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $4.8 Million - $7.32 Million	111,572 New	111,572 $6.37 Million
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $1.01 Million - $1.63 Million	-26,177 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $921,430 - $1.4 Million	26,177 New	26,177 $1.37 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $4.33 Million - $6.41 Million	-150,783 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $4.42 Million - $6.71 Million	150,783 New	150,783 $6.16 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.